Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
MI FOLFOXai
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Caris Life Sci
Type:
Laboratory Developed Test
Related tests:
‹
Caris Assure™
MI Tumor Seek™
Caris Assure™
MI Tumor Seek™
›
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
almost3years
Navigate mCRC Standard-of-Care Chemotherapy with MI FOLFOXai Now oncologists have an Artificial Intelligence (AI)-based predictor intended to gauge a mCRC patient’s likelihood of benefit from first-line FOLFOX+BV followed by FOLFIRI+BV versus FOLFIRI+BV followed by FOLFOX+BV. (@JohnFortner5)
almost 3 years ago
Clinical
|
MI FOLFOXai
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login